Syndax Pharmaceuticals Inc (SNDX) [Rocket]

In millions, except per share items	Jun-30-23	Jun-05-23	Mar-31-23	Mar-05-23	Jun-30-22	Jun-05-22	Mar-31-22	Mar-05-22
	10-Q	8-K	10-Q	8-K	10-Q	8-K	10-Q	8-K
Total revenues [+]	0.0	34.8	0.0	34.1	0.0	29.7	0.0	30.0
Royalties		34.8		34.1		29.7		30.0
Revenue growth		16.9%		13.4%	-100.0%		-100.0%
Cost of goods sold	0.0	69.5	0.0	68.1	0.0	59.5	0.0	60.0
Gross profit	0.0	-34.8	0.0	-34.1	0.0	-29.7	0.0	-30.0
Gross margin		-100.0%		-100.0%		-100.0%		-100.0%
Selling, general and administrative [+]	49.7	14.9	46.0	12.0	37.7	8.0	36.9	6.8
General and administrative		14.9		12.0		8.0		6.8
Other selling, general and administrative
Research and development
Other operating expenses	-10.1		-9.8		-0.3		0.6
EBITDA [+]
Depreciation and amortization
EBIT [+]	-39.6	-49.7	-36.2	-46.0	-37.4	-37.7	-37.5	-36.9
EBIT growth	5.7%	31.7%	-3.3%	24.8%	59.3%		38.0%
EBIT margin		-142.9%		-135.1%		-126.9%		-122.8%
Interest income, net [+]	5.2		5.1		0.9		0.2
Interest expense	0.0		0.0		0.7		0.7
Interest income	5.2		5.1		0.9		0.2
Other income (expense), net	-10.2	5.1	-9.9	4.9	-0.3	0.2	0.7	-0.3
Pre-tax income	-44.6	-44.6	-41.1	-41.1	-37.6	-37.6	-37.2	-37.2
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-44.6	-44.6	-41.1	-41.1	-37.6	-37.6	-37.2	-37.2
Net margin		-128.3%		-120.8%		-126.4%		-123.8%

Basic EPS [+]	($0.64)	($44,615.00)	($0.59)	($41,126.00)	($0.62)	($37,572.00)	($0.63)	($37,169.00)
Growth	2.6%	18.7%	-6.0%	10.6%	40.7%		17.1%
Diluted EPS [+]	($0.64)	($44,615.00)	($0.59)	($41,126.00)	($0.62)	($37,572.00)	($0.63)	($37,169.00)
Growth	2.6%	18.7%	-6.0%	10.6%	40.7%		17.1%

Shares outstanding (basic) [+]	69.6	0.0	69.4	0.0	60.2	0.0	59.0	0.0
Growth	15.8%	0.0%	17.7%	0.0%	16.6%		14.5%
Shares outstanding (diluted) [+]	69.6	0.0	69.4	0.0	60.2	0.0	59.0	0.0
Growth	15.8%	0.0%	17.7%	0.0%	16.6%		14.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.